Would Abbott's antigen test solve COVID-19 testing problems? Stakeholders emphasize caution
Skip to main content
MDHC_Logotype_white
Subscribe
  • My Account
  • Login
  • Subscribe
  • News
    • This Week's News
    • COVID-19
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • People
    • Regional News
    • Digital Edition
    • Biden to reopen 'Obamacare' markets for COVID-19 relief
      Hospitals push CMS to pause 'most favored nation' drug-pricing rule
      Prime Healthcare settles with union workers, agrees to $458,000 in backpay
      Biden administration warns fully meeting vaccine demand could take 'months'
    • Biden to reopen 'Obamacare' markets for COVID-19 relief
      Biden administration warns fully meeting vaccine demand could take 'months'
      Hospital system rebuked after offering vaccine to donors
      Thousands of Portland's healthcare workers not vaccinated
    • Thousands of Portland's healthcare workers not vaccinated
      Ascension’s St. Mary’s Hospital Surgery Center at Towne Centre and Allegheny Health Network’s Bethel Park surgery center
      Hospitals see opportunity, risk in ambulatory surgery centers
      Health suffers as rural hospitals close
      Medicare ACO participants fell in 2021
    • Billing, antitrust exemption changes upend negotiations between insurers and providers
      MAIN-Health Bill_iStock_i.jpg
      Insurance-tech firm MultiPlan makes $155M buy after blank-check deal
      Last-minute COVID costs cut into UnitedHealthcare's $396 million operating income
      CMS approves rule forcing insurers to ease prior authorization
    • Biden to reopen 'Obamacare' markets for COVID-19 relief
      Hospitals push CMS to pause 'most favored nation' drug-pricing rule
      Regulation Tracker: Biden reviews Trump's final rules
      Hospital system rebuked after offering vaccine to donors
    • Anthem's Q4 profits drop 41% with added COVID costs, patient care
      jesse ford salud revenue partners headshot
      Sponsored Content Provided By Salud Revenue Partners
      How to succeed on self-pay: think ‘balance integrity’
      KPMG says deal activity will stay high in '21: 10 takeaways
      By the Numbers: 20 largest healthcare investment banks in 2020
    • Studies extend hopes for antibody drugs against COVID-19
      Google to convert office space for COVID-19 vax clinics
      Next Up Podcast: What to expect with telehealth and healthcare technology in the next 4 years - Transcript
      Dr. Karen DeSalvo
      Next Up Podcast: What to expect with telehealth and healthcare technology in the next four years
    • Amid COVID health worker shortage, foreign-trained professionals sit on sidelines
      China pushes conspiracy theories on COVID origin, vaccines
      Avocado
      Avocado a day keeps the doctor away
      50% of Americans make resolutions. Fewer than 27% keep them over time.
      Data Points: Sticking with your resolutions
    • Humana names first chief equity officer
      WEb_i.jpg
      Q&A: Dr. Cliff Megerian, University Hospitals' soon-to-be CEO
      ZentyWeb_i.jpg
      Tom Zenty is leaving a legacy of transformational growth at University Hospitals
      Cerner names Erceg as new CFO
    • Midwest
    • Northeast
    • South
    • West
  • Insights
    • ACA 10 Years After
    • Best Practices
    • InDepth Special Reports
    • Innovations
    • The Affordable Care Act after 10 years
    • New care model helps primary-care practices treat obesity
      doctor with patient
      COVID-19 treatment protocol developed in the field helps patients recover
      Rachel Wyatt
      Project to curb pressure injuries in hospitals shows promise
      Yale New Haven's COVID-19 nurse-staffing model has long-term benefits
    • Modern Healthcare InDepth: Breaking the bias that impedes better healthcare
      Videos: Healthcare industry executives describe their encounters with racism
      Michellene Davis
      Healthcare leadership lacks the racial diversity needed to reduce health disparities
      Dr. James Hildreth
      How medical education can help fight racism
      Quotes from rebadged employees
      Outsourcing IT, revenue cycle takes toll on internal culture
    • A phone screen showing the question, "Mary we hope this information was helpful and we'd like to keep guiding you. Are you interested in knowing when it's your turn to receive the vaccine?"
      Chatbots, texting campaigns help manage influx of COVID vax questions
      A woman with a wearable sensor talking to her provider.
      Wearable sensors help diagnose heart rhythm problems in West Virginia
      self service station
      COVID-19 pushes patient expectations toward self-service
      Targeting high-risk cancer patients with genetics
  • Transformation
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Highmark Health inks six-year cloud, tech deal with Google
      Study: 1 in 5 patients report discrimination when getting healthcare
      HHS proposes changing HIPAA privacy rules
      Android health records app launches at 230 health systems
    • California hospitals prepare ethical protocol to prioritize lifesaving care
      Amazon, JPMorgan Chase, Berkshire Hathaway disband Haven
      Digital pathways poised to reshape healthcare continuum in 2021
      Healthcare was the hardest hit by supply shortages across all U.S. industries
    • A phone screen showing the question, "Mary we hope this information was helpful and we'd like to keep guiding you. Are you interested in knowing when it's your turn to receive the vaccine?"
      Chatbots, texting campaigns help manage influx of COVID vax questions
      A woman with a wearable sensor talking to her provider.
      Wearable sensors help diagnose heart rhythm problems in West Virginia
      New care model helps primary-care practices treat obesity
      How hospitals are building on COVID-19 telehealth momentum
    • Regional insurers bet big on virtual-first plans
      MedPAC votes to boost hospital payments, freeze or cut other providers
      Most Next Gen ACOs achieved bonuses in 2019
      Congress recalibrates Medicare Physician Fee Schedule after lobbying
  • Data/Lists
    • Rankings/Lists
    • Interactive Databases
    • Data Points
    • Health Systems Financials
      Executive Compensation
      Physician Compensation
  • Op-Ed
    • Bold Moves
    • Breaking Bias
    • Commentaries
    • Letters
    • Vital Signs Blog
    • From the Editor
    • Wellstar CEO calls adapting for the pandemic her bold move
      Howard P. Kern
      Recognizing the value of telehealth in its infancy
      Dr. Stephen Markovich
      A bold move helped take him from family doctor to OhioHealth CEO
      Dr. Bruce Siegel
      Why taking a hospital not-for-profit was Dr. Bruce Siegel’s boldest move
    • Barry Ostrowsky
      Ending racism is a journey taken together; the starting point must be now
      Laura Lee Hall and Gary Puckrein
      Increased flu vaccination has never been more important for communities of color
      John Daniels Jr.
      Health equity: Making the journey from buzzword to reality
      Mark C. Clement and David Cook
      We all need to 'do something' to fight inequities and get healthcare right, for every patient, every time
    • The missing piece in our fight against COVID-19: primary care
      Ambulatory surgery centers offer extraordinary value in a high-cost healthcare system
       Alan B. Miller
      Looking ahead with optimism as we continue to transform healthcare
      Dr. Bruce Siegel
      By protecting the healthcare safety net, Biden can put us on the path to a stronger country
    • Letters: Eliminating bias in healthcare needs to be ‘deliberate and organic’
      Letters: Maybe dropping out of ACOs is a good thing for patients
      Letters: White House and Congress share blame for lack of national COVID strategy
      Letters: VA making strides to improve state veterans home inspections
    • Sponsored Content Provided By Optum
      How blockchain could ease frustration with the payment process
      Sponsored Content Provided By Optum
      Three steps to better data-sharing for payer and provider CIOs
      Sponsored Content Provided By Optum
      Reduce total cost of care: 6 reasons why providers and payers should tackle the challenge together
      Sponsored Content Provided By Optum
      Why CIOs went from back-office operators to mission-critical innovators
  • Awards
    • Award Programs
    • Nominate
    • Previous Award Programs
    • Other Award Programs
    • Best Places to Work in Healthcare Logo for Navigation
      Nominations Open - Best Places to Work in Healthcare
      Nominations Closed - Health Care Hall of Fame
      Nominations Open - 50 Most Influential Clinical Executives
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top 25 Innovators
    • Top 25 Minority Leaders
    • Top 25 Women Leaders
    • Excellence in Nursing Awards
    • Design Awards
    • Top 25 COOs in Healthcare
    • 100 Top Hospitals
    • ACHE Awards
  • Events
    • Conferences
    • Galas
    • Webinars
    • COVID-19 Event Tracker
    • ntt data logo lockup webinar
      Sponsored Content Provided By NTT DATA
      Webinar: Mistakes I’ve Made — Confessions of a Healthcare Cybersecurity Expert
      bright.md logo lockup webinar
      Sponsored Content Provided By Bright.md
      Webinar: Enabling a hybrid care model — Streamlining the patient path to both telehealth and in-person care
    • Leadership Symposium
    • Healthcare Transformation Summit
    • Women Leaders in Healthcare Conference
    • Workplace of the Future Conference
    • Strategic Marketing Conference
    • Social Determinants of Health Symposium
    • Best Places to Work Awards Gala
    • Health Care Hall of Fame Gala
    • Top 25 Minority Leaders Gala (2022)
    • Top 25 Women Leaders Gala
  • Listen
    • Podcast - Next Up
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Video Series - The Check Up
    • Sponsored Video Series - One on One
    • Dr. Karen DeSalvo
      Next Up Podcast: What to expect with telehealth and healthcare technology in the next four years
      Carter Dredge
      Next Up Podcast: Ready, set, innovate! Innovation and disruption in healthcare
      Next Up Podcast: COVID-19, social determinants highlight health inequities — what next?
      Ceci Connolly
      Next Up Podcast: How to navigate the murky post-election waters
    • Beyond the Byline: Regulators aim to boost value push with fraud and abuse law updates
      An older man wearing a mask receiving a vaccine.
      Beyond the Byline: Verifying information on the chaotic COVID-19 vaccine rollout
      doctor burnout
      Beyond the Byline: How healthcare supply chain struggles contribute to employee burnout
      Beyond the Byline: Covering race and diversity in the healthcare industry
    • Leading intention promote diversity and inclusion
      Introducing Healthcare Insider Podcast
    • The Check Up: Dr. Joseph Kerschner
      The Check Up: Dr. Joseph Kerschner of the Medical College of Wisconsin
      The Check Up: Chip Kahn
      The Check Up: Chip Kahn of the Federation of American Hospitals
      The Check Up: Trenda Ray
      The Check Up: Trenda Ray of the University of Arkansas for Medical Sciences
      The Check Up: Dr. Kenneth Davis
      The Check Up: Dr. Kenneth Davis of Mount Sinai Health System
    • Video: Ivana Naeymi Rad of Intelligent Medical Objects
  • MORE +
    • Advertise
    • Media Kit
    • Newsletters
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Supply Chain
September 01, 2020 12:32 PM

Would Abbott's antigen test solve COVID-19 testing problems? Stakeholders emphasize caution

Kelsy Ketchum, 360Dx
  • Tweet
  • Share
  • Share
  • Email
  • More
    Print

    With no signs that the coronavirus pandemic is anywhere close to abating, many have pointed to the need for an easy-to-use, quick and inexpensive test that could identify those with SARS-CoV-2 relatively accurately.

    Last week, Abbott Laboratories appeared to answer that call when its antigen test received emergency use authorization, making it the sixth test for the coronavirus in Abbott's portfolio.

    But members of the laboratory community stressed cautious expectations for the test, saying they can be used by untrained personnel and may be vulnerable to improper handling, leading to incorrect results.

    Protein-based antigen tests have become more popular in recent months as test developers aim to address the ever-increasing demand for COVID-19 tests. The fast turnaround time, ease of use, and ability to ramp up production quickly make them appealing options as outbreaks continue across the U.S. So far, Quidel, Becton Dickinson, and LumiraDx have received EUA for rapid antigen tests.

    Unlike those rapid antigen tests, or molecular COVID-19 tests, the Abbott test doesn't require an analyzer to read results. It can tell whether someone has the SARS-CoV-2 virus in 15 minutes from a nasal swab that is twirled on a test card with a reagent added, and similar to a pregnancy test, results can be read directly from the card, with one line indicating a negative result and two lines indicating a positive result, according to the Food and Drug Administration. It is authorized for use within seven days of symptoms at doctors' offices, emergency departments, and schools, the agency said.

    The test is accompanied by a free phone app, Navica, that can display the results and the date of the result when requested. Andrea Wainer, executive vice president of rapid and molecular diagnostics at Abbott, said during a press briefing that the encrypted results will look like a boarding pass that can be scanned by a verifier to enter a facility.

    Abbott announced the test will retail for $5 and it plans to ship "tens of millions" of tests in September, ramping to 50 million tests per month in October, although it is still finalizing distribution plans. The test has a sensitivity of 97% and specificity of 98.5%, and it qualitatively detects the nucleocapsid protein antigen from SARS-CoV-2. The FDA noted in its EUA that antigen tests may be less sensitive than molecular tests, so a negative result could require confirmation from a molecular test.

    The federal government has shown faith in the test, announcing last week it had purchased 150 million tests to expand evidence-based testing in the U.S., according to HHS. The tests will potentially be deployed to schools and "other special needs populations," the agency said.

    Abbott's assay comes as testing shortages have continued throughout the nation, due to supply chain issues and high demand. Abbott has positioned the test as a solution to the need for "massive scale testing," Wainer said, adding, "We can get to more places and more people and more frequently with a fast result."

    The manufacturing ramp-up will be essential to meet continued demand for testing. "For us to be able to control this (pandemic), we need to have results in real time, where patients can hear them and then obviate their behavior based on what they've heard," said Frank Peacock, research director for the department of emergency medicine at Baylor College of Medicine, during Abbott's media call.

    John Hackett, Abbott's divisional vice president of applied research and technology in the diagnostics business, also noted on the media call that the test can be used "as a first line of defense" to identify people who are currently infected to prevent spread of the virus. He said Abbott designed the test to address multiple critical components of COVID-19 testing, including speed, access, affordability and accuracy.

    Susan Van Meter, executive director of diagnostics advocacy group AdvaMedDx, emphasized in an email the importance of increasing access to testing, writing that innovations like the Abbott test are "democratizing access to coronavirus tests and ensuring access to results as quickly as possible."

    In particular, the low cost of the test because "affordability is critical to get our tests out to as many people as we can," Wainer added. She said Abbott chose to use antigen technology because it would be able to get to a more affordable price point, and the $5 kit includes the card, the swab and the buffer.

    Despite the solid performance data and ease of use, some members of the laboratory community have their doubts about how significant the impact of the test will be. Dr. Emily Volk, president-elect of the College of American Pathologists, noted that Abbott will have to make sure the end users know exactly how to use the test and interpret the results.

    She mentioned that variables, such as improper collection of a sample, not applying the sample to the card properly, or not running and interpreting the results within the appropriate time limits could lead to inaccurate results. Volk also emphasized that there is less direct oversight at the point of care than in a centralized laboratory, which could impact proper use of the test. "That's a lot of ifs, and we don't live in a world that's that controlled," Volk said.

    She did add that the rapid turnaround time could help expand availability, as long as Abbott is able to produce enough tests. The supply chain issues that have compromised the U.S. response to the pandemic shouldn't be a problem for this test, Volk said, since it uses a different supply chain than molecular tests.

    "I think it's very possible this will have some impact, but I don't see this revolutionizing or significantly decreasing the need for PCR tests in commercial laboratories," Volk said. "I do not see it as being a substitute for PCR tests in the acute-care setting."

    Dr. Alex Greninger, assistant director of the University of Washington Medicine clinical virology laboratories and an assistant professor of laboratory medicine at the university, noted in an email the limited performance data in the EUA and said the most important aspect is that it was only evaluated for symptomatic patients, which he called "a moderately different use case than something manufactured at" 1 million to 1.5 million a day, He added that it would be interesting to see how the specificity of the test holds up if it is run at that volume.

    The lack of a required instrument makes Abbott's test stand out from the rest in terms of access, since the other antigen tests that have received EUA each require instrumentation.

    While rapid antigen tests have shown to be less accurate than molecular tests, in general, some have advocated for their use during the pandemic in order to ramp up testing, saying the lower sensitivity of antigen tests is made up for by their ease of use and potential to get more people tested.

    According to Dr. Michael Mina, an assistant professor of epidemiology at Harvard's T.H. Chan School of Public Health, because the rapid antigen tests are reserved for use within a week of symptoms, the positive result comes when patients are often still transmitting the virus. During the recent spike in coronavirus cases during the summer, some commercial labs took up to two weeks to report COVID-19 molecular test results. Such a delay could lead to a positive result for a patient who is no longer contagious, resulting in erroneous quarantines. "People actually test positive for much longer on PCR than they do on antigen tests," Mina said on a call with reporters.

    Mina also said he thinks Abbott's test, and other rapid antigen tests that may follow, could be used for asymptomatic patients and over-the-counter use. "I think having a test that can really find you when you're transmissible is the whole goal here," Mina said. When results are quick, the transmission chain can be stopped and outbreaks can be avoided, he added, and as COVID-19 tests go over-the-counter, there will need to be flexibility in how results are reported, since many patients could be testing from home.

    "The tests could have an impact," Volk said. "It really depends on who gets them and how they get them and in what quantity."

    This story first appeared in Modern Healthcare sister publication 360Dx, which provides in-depth coverage of in vitro diagnostics and the clinical lab market.

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    Lab stakeholders welcome Biden moves on COVID-19 testing, suggest additional steps
    Lab stakeholders welcome Biden moves on COVID-19 testing, suggest additional steps
    J&J 4Q sales rise despite pandemic, but charges cut profits
    J&J 4Q sales rise despite pandemic, but charges cut profits
    Sponsored Content
    Get Free Newsletters

    Sign up for free enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today

    The weekly magazine, websites, research and databases provide a powerful and all-encompassing industry presence. We help you make informed business decisions and lead your organizations to success.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS
    • Instagram

    Stay Connected

    Join the conversation with Modern Healthcare through our social media pages

    MDHC_Logotype_white
    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Advertise with Us
    • Ad Choices Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2021. Crain Communications, Inc. All Rights Reserved.
    • News
      • This Week's News
      • COVID-19
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition
    • Insights
      • ACA 10 Years After
      • Best Practices
      • InDepth Special Reports
      • Innovations
    • Transformation
      • Patients
      • Operations
      • Care Delivery
      • Payment
    • Data/Lists
      • Rankings/Lists
      • Interactive Databases
      • Data Points
    • Op-Ed
      • Bold Moves
      • Breaking Bias
      • Commentaries
      • Letters
      • Vital Signs Blog
      • From the Editor
    • Awards
      • Award Programs
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • Best Places to Work in Healthcare
        • Health Care Hall of Fame
        • Healthcare Marketing Impact Awards
        • Top 25 Emerging Leaders
        • Top 25 Innovators
        • Top 25 Minority Leaders
        • Top 25 Women Leaders
      • Nominate
      • Previous Award Programs
        • Excellence in Nursing Awards
        • Design Awards
        • Top 25 COOs in Healthcare
      • Other Award Programs
        • 100 Top Hospitals
        • ACHE Awards
    • Events
      • Conferences
        • Leadership Symposium
        • Healthcare Transformation Summit
        • Women Leaders in Healthcare Conference
        • Workplace of the Future Conference
        • Strategic Marketing Conference
        • Social Determinants of Health Symposium
      • Galas
        • Best Places to Work Awards Gala
        • Health Care Hall of Fame Gala
        • Top 25 Minority Leaders Gala (2022)
        • Top 25 Women Leaders Gala
      • Webinars
      • COVID-19 Event Tracker
    • Listen
      • Podcast - Next Up
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Video Series - The Check Up
      • Sponsored Video Series - One on One
    • MORE +
      • Advertise
      • Media Kit
      • Newsletters
      • Jobs
      • People on the Move
      • Reprints & Licensing